CooperCompanies Announces Release Date for Second Quarter 2026
Rhea-AI Summary
CooperCompanies (Nasdaq: COO) will report Q2 2026 financial results on Thursday, June 4, 2026 at 4:15 PM ET. A conference call will follow at 5:00 PM ET to discuss results and corporate developments.
Dial-in: 800-715-9871 (Conference ID: 6529381). A simultaneous audio webcast and replay will be available at www.investor.coopercos.com.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – COO
On the day this news was published, COO declined 0.86%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 09 | Sustainability initiative | Positive | -0.4% | Launch of MADE BETTER Promise using certified bio-attributed plastics and recycling gains. |
| Mar 05 | Quarterly earnings | Positive | -4.5% | Q1 FY2026 beat with raised full-year revenue, EPS, and free cash flow guidance. |
| Feb 10 | Product launch | Positive | +0.1% | Launch of MiSight 1 day in Japan for pediatric myopia control. |
| Feb 05 | Earnings date notice | Neutral | +2.5% | Announcement of Q1 2026 earnings release timing and conference call details. |
| Dec 29 | Conference appearance | Neutral | +0.3% | Planned presentation at J.P. Morgan Healthcare Conference with webcast access. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent positive operating updates have sometimes seen muted or negative next-day price reactions.
Over the last few months, COO has combined product expansion, corporate events, and earnings. On Feb 10, 2026, the MiSight® 1 day launch in Japan produced a small 0.11% gain despite strong clinical and market positioning. Q1 FY2026 earnings on Mar 5 with raised guidance to $4.306–$4.346 billion revenue led to a -4.55% move. Event notices such as the J.P. Morgan conference and prior earnings release dates saw modest, mixed reactions, framing today’s Q2 release-date announcement as part of a regular communications cadence.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAMON, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report second quarter 2026 financial results on Thursday, June 4, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The dial-in number for the call is 800-715-9871 and the conference ID is 6529381. A simultaneous audio webcast and subsequent replay can be accessed at www.investor.coopercos.com
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
